In our case, IHC analysis for LS-related tumors was informative and identified loss of MSH2 and MSH6 expression in the ACC and endometrial tumors analyzed from affected patients with the germline MSH2 mutation. Here, MSH6 is linked to adrenal cortex carcinoma.